RT @venkmurthy: @onco_cardiology @almallahmo @NitiCardio @DorbalaSharmila You can get down to vanishingly small post-test probability depen…
@onco_cardiology @almallahmo @NitiCardio @DorbalaSharmila You can get down to vanishingly small post-test probability depending on what the CFR is. See figure 2 in this paper. https://t.co/YPLffN1Cw5
RT @venkmurthy: Folks who are spreading misinformation that there is no way to evaluate for LM disease except ICA or CCTA please read this:…
RT @venkmurthy: Folks who are spreading misinformation that there is no way to evaluate for LM disease except ICA or CCTA please read this:…
RT @venkmurthy: Folks who are spreading misinformation that there is no way to evaluate for LM disease except ICA or CCTA please read this:…
RT @venkmurthy: Folks who are spreading misinformation that there is no way to evaluate for LM disease except ICA or CCTA please read this:…
RT @venkmurthy: Folks who are spreading misinformation that there is no way to evaluate for LM disease except ICA or CCTA please read this:…
Folks who are spreading misinformation that there is no way to evaluate for LM disease except ICA or CCTA please read this: https://t.co/703Nrgnin1
@afshinfarzan @cshenoy3 @onco_cardiology @mgwfriedrich @HeartDocSubha And probability of LM can be assessed to be minimal with PET based on CFR. https://t.co/703Nrgnin1
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomog... http://t.co/RTDh8fXg #nucmed